filipe-frazao-shutterstock-com-1
Filipe Frazao / Shutterstock.com
2 July 2015BiotechGabriel Di Blasi

Exploit and protect

In May, the Brazilian government signed the new Brazilian Law No. 13.123/15, which regulates access to national biodiversity. The new law, which will become effective in November, comes as a substitute for the current Provisional Act No. 2.186-16/01, which regulates access to national genetic heritage, as well as the associated traditional knowledge (ATK). The provisional act came at a time when Brazil needed to integrate the principles of the Convention on Biological Diversity (CBD) in 1992, which took place in Rio de Janeiro.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Biotech
29 September 2026   The gene-editing company has accused a former employee of secretly co-founding a Chinese biotech while still at the company, in a trade secrets lawsuit involving rival base-editing therapies and disputed patent filings.
Biotech
21 September 2026   Judges agreed with the Oxford University spin-out that MGI Tech was likely to infringe Oxford’s patent, and banned sales of certain Cyclone devices to preserve the one-player-market status quo.
Biotech
16 September 2026   BMS is stepping up its defence of its blockbuster cancer drug Opdivo as Amgen moves closer to the biosimilar market.